Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Jul;115(6):1013–1019. doi: 10.1111/j.1476-5381.1995.tb15912.x

Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord.

B A Chizh 1, M J Cumberbatch 1, P J Birch 1, P M Headley 1
PMCID: PMC1908992  PMID: 7582497

Abstract

1. The effects of selective tachykinin (neurokinin, NK) NK1 and NK2 receptor antagonists have been examined on spinal neurones in alpha-chloralose anaesthetized, spinalized rats. They were tested for effects on responses both to excitatory amino acids (EAA) and to noxious heat stimuli. They were also tested for their ability to reverse the actions of selective NK agonists. 2. The NK1-selective antagonists GR82334 (peptide) and CP-99,994 (non-peptide), when applied by microiontophoresis, both reduced responses to kainate > AMPA > NMDA. Intravenous CP-99,994 (3 mg kg-1) also reduced responses to kainate but had inconsistent effects on nociceptive responses. 3. GR82334, applied microiontophoretically, reduced the enhancement by the selective NK1 agonist, GR73632 of both responses to EAAs and background activity. Systemic CP-99,994 (< or = 10 mg kg-1) failed to reverse the effects of GR73632. 4. The selective peptide NK2 antagonist, GR103537, had no consistent effects on responses to EAAs when applied by iontophoresis. In contrast, the non-peptide NK2 antagonist, GR159897, administered systemically (0.5-2 mg kg-1, i.v.) enhanced responses to kainate (but not NMDA); responses to noxious heat were enhanced only weakly. 5. Iontophoretically-administered GR103537 attenuated the effects of the NK2 agonist GR64349, which selectively reduced responses to kainate compared to those to NMDA. Systemically administered GR159897 (< or = 2 mg kg-1, i.v.) caused little antagonism of the effects of GR64349. 6. The data indicate that under these conditions the non-peptide antagonists are not reliable at reversing the actions of selective NK agonists.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1013

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birch P. J., Harrison S. M., Hayes A. G., Rogers H., Tyers M. B. The non-peptide NK1 receptor antagonist, (+/-)-CP-96,345, produces antinociceptive and anti-oedema effects in the rat. Br J Pharmacol. 1992 Mar;105(3):508–510. doi: 10.1111/j.1476-5381.1992.tb09008.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cumberbatch M. J., Chizh B. A., Headley P. M. Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord. Br J Pharmacol. 1995 Jul;115(6):1005–1012. doi: 10.1111/j.1476-5381.1995.tb15911.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dalsgaard C. J., Haegerstrand A., Theodorsson-Norheim E., Brodin E., Hökfelt T. Neurokinin A-like immunoreactivity in rat primary sensory neurons; coexistence with substance P. Histochemistry. 1985;83(1):37–39. doi: 10.1007/BF00495297. [DOI] [PubMed] [Google Scholar]
  4. De Biasi S., Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7820–7824. doi: 10.1073/pnas.85.20.7820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dougherty P. M., Willis W. D. Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain. 1991 Oct;47(1):85–93. doi: 10.1016/0304-3959(91)90015-P. [DOI] [PubMed] [Google Scholar]
  6. Duggan A. W., Hendry I. A., Morton C. R., Hutchison W. D., Zhao Z. Q. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res. 1988 Jun 7;451(1-2):261–273. doi: 10.1016/0006-8993(88)90771-8. [DOI] [PubMed] [Google Scholar]
  7. Duggan A. W., Hope P. J., Jarrott B., Schaible H. G., Fleetwood-Walker S. M. Release, spread and persistence of immunoreactive neurokinin A in the dorsal horn of the cat following noxious cutaneous stimulation. Studies with antibody microprobes. Neuroscience. 1990;35(1):195–202. doi: 10.1016/0306-4522(90)90134-p. [DOI] [PubMed] [Google Scholar]
  8. Fleetwood-Walker S. M., Parker R. M., Munro F. E., Young M. R., Hope P. J., Mitchell R. Evidence for a role of tachykinin NK2 receptors in mediating brief nociceptive inputs to rat dorsal horn (laminae III-V) neurons. Eur J Pharmacol. 1993 Sep 28;242(2):173–181. doi: 10.1016/0014-2999(93)90077-u. [DOI] [PubMed] [Google Scholar]
  9. Hagan R. M., Beresford I. J., Stables J., Dupere J., Stubbs C. M., Elliott P. J., Sheldrick R. L., Chollet A., Kawashima E., McElroy A. B. Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists. Regul Pept. 1993 Jul 2;46(1-2):9–19. doi: 10.1016/0167-0115(93)90005-s. [DOI] [PubMed] [Google Scholar]
  10. Hartell N. A., Headley P. M. Preparative surgery enhances the direct spinal actions of three injectable anaesthetics in the anaesthetized rat. Pain. 1991 Jul;46(1):75–80. doi: 10.1016/0304-3959(91)90036-W. [DOI] [PubMed] [Google Scholar]
  11. Mantyh P. W., Gates T., Mantyh C. R., Maggio J. E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci. 1989 Jan;9(1):258–279. doi: 10.1523/JNEUROSCI.09-01-00258.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McLean S., Ganong A., Seymour P. A., Snider R. M., Desai M. C., Rosen T., Bryce D. K., Longo K. P., Reynolds L. S., Robinson G. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharmacol Exp Ther. 1993 Oct;267(1):472–479. [PubMed] [Google Scholar]
  13. Merighi A., Polak J. M., Theodosis D. T. Ultrastructural visualization of glutamate and aspartate immunoreactivities in the rat dorsal horn, with special reference to the co-localization of glutamate, substance P and calcitonin-gene related peptide. Neuroscience. 1991;40(1):67–80. doi: 10.1016/0306-4522(91)90175-n. [DOI] [PubMed] [Google Scholar]
  14. Mjellem-Joly N., Lund A., Berge O. G., Hole K. Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acid agonists. Neurosci Lett. 1991 Nov 25;133(1):121–124. doi: 10.1016/0304-3940(91)90072-2. [DOI] [PubMed] [Google Scholar]
  15. Randall M. D., Ujiie H., Griffith T. M. Modulation of vasodilatation to levcromakalim by adenosine analogues in the rabbit ear: an explanation for hypoxic augmentation. Br J Pharmacol. 1994 May;112(1):49–54. doi: 10.1111/j.1476-5381.1994.tb13027.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rusin K. I., Ryu P. D., Randic M. Modulation of excitatory amino acid responses in rat dorsal horn neurons by tachykinins. J Neurophysiol. 1992 Jul;68(1):265–286. doi: 10.1152/jn.1992.68.1.265. [DOI] [PubMed] [Google Scholar]
  17. Skilling S. R., Smullin D. H., Beitz A. J., Larson A. A. Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J Neurochem. 1988 Jul;51(1):127–132. doi: 10.1111/j.1471-4159.1988.tb04845.x. [DOI] [PubMed] [Google Scholar]
  18. Wang Z. Y., Tung S. R., Strichartz G. R., Håkanson R. Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission. Br J Pharmacol. 1994 Jan;111(1):179–184. doi: 10.1111/j.1476-5381.1994.tb14041.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Xu X. J., Dalsgaard C. J., Wiesenfeld-Hallin Z. Spinal substance P and N-methyl-D-aspartate receptors are coactivated in the induction of central sensitization of the nociceptive flexor reflex. Neuroscience. 1992 Dec;51(3):641–648. doi: 10.1016/0306-4522(92)90303-j. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES